Pharmaceutical

Incyte and Genesis collaborate on small-molecule medicines

Incyte and Genesis have entered a strategic partnership for the research, discovery and development of new small-molecule medicines.

Feb 23, 2025 - 06:00
Incyte and Genesis collaborate on small-molecule medicines
Incyte and Genesis have entered a strategic partnership for the research, discovery and development of new small-molecule medicines.
Read the original article

Tags:

Previous Article

NICE green lights two blood cancer therapies for NHS use

Next Article

Navigating the Complexities of Sustainable Specialty Pharma Supply Chains

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Sanofi completes the $1.7bn acquisition of Inhibrx

Sanofi completes the $1.7bn acquisition of Inhibrx

May 31, 2024

Bristol Myers Squibb’s Breyanzi receives EC approval to treat LBCL

Bristol Myers Squibb’s Breyanzi receives EC approval to...

May 4, 2023

Life expectancy for men in U.S. falls to 73 years — six years less than for women, per study

Life expectancy for men in U.S. falls to 73 years — six...

Nov 13, 2023